Therefore, less availability of TGFβ1 protein due to PFD-mediated inhibition of TGFβ1 protein secretion is the probable explanation for the decreased concentration of active TGFβ1 in mice treated with PFD. Here, TGFB1 is linked to polyostotic fibrous dysplasia.